Tumor Marker Ordering: Do Not Lose Control: A Prospective Clinical Trial

Abstract

Our data show that real-time control and management of inappropriate requests by laboratory professionals may be relevant to increase the clinical efficacy of TM testing and useful in perspective to drive the introduction of new validated biomarkers.